Cognition and MS – Presented by Dr Dawn Langdon
Wednesday 20 October at 7pm via Zoom
We are pleased to welcome Dr Dawn Langdon who is Professor of Neuropsychology at Royal Holloway, University of London and a Fellow of the British Psychological Society. Dawn is a frequent contributor to international scientific meetings and committees and is a Trustee of the UK MS Trust, with whom she has authored the MS cognition website www.stayingsmart.org.uk. Dr Landon has provided articles in our New Pathways magazine (issue 127) and blogs for MS-UK in the past.
So we are extremely fortunate to have Dr Langdon present on behalf of MS-UK with her extensive knowledge in neuropsychology and in particular within MS. This workshop will provide an overview of the cognitive challenges in MS, including the pattern of difficulties, the relation to disease variables and how cognitive challenges impact everyday life and wellbeing. Dr Langdon will then present the treatment options and resources available.
If you can’t make the session live, don’t worry as we will be recording the presentation and will make it available to watch again for all those registering in advance.
We have a suggested donation is £5 for this information session, but you can make a donation of your choosing from £1 to attend.
If you would like to know more about this session or would like help in registering, please email firstname.lastname@example.org.
More about Dr Dawn Langdon
Dr Langdon completed her training as a clinical psychologist at Oxford University and the Institute of Psychiatry, KCL. She worked as a clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London for sixteen years, obtaining a PhD on reasoning in organic brain syndromes from the Institute of Neurology, UCL and registration as both a neuropsychologist and a health psychologist.
Dr Langdon is neuropsychology lead on a number of multinational trials for the pharmaceutical industry. She has worked extensively on psychological aspects of MS, including measurement of cognition and its relation to pathology and other disease variable, also investigating how risks and benefits of MS medication are best communicated to patients, including a successful randomised control trial comparing the new protocol to consultation as usual. Other interests are how employment relates to cognition in MS and how psychological variables influence adherence.
She is Co-Chair of the BICAMS initiative, which has recommended a brief cognition tool for MS. There are currently 36 countries in the national validation pipeline, of whom 24 have published. The AAN have recommended BICAMS as part of its Quality Measurement Set for MS. Over 30 peer review journal articles recommend BICAMS for routine assessment. BICAMS has been used in a number of international pharma trials and also in other investigations of MS cognition relating to imaging, employment and everyday life tasks; in total 100 scientific papers have reported BICAMS results. Dawn Langdon has led on the development of IPAD BICAMS.
Sign up to join this event
Book your slot